Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.
Document Type
Article
Publication Date
10-2024
Publication Title
Infectious diseases and therapy
Volume
13
Issue
10
First Page
2209
Last Page
2210
Recommended Citation
Kraft CS, Sims M, Silverman M, Louie TJ, Feuerstadt P, Huang ES, et al Correction to: integrated safety and efficacy analyses of phase 3 trials of a microbiome therapeutic for recurrent cdi. Infect Dis Ther. 2024 Oct;13(10):2209-2210. doi: 10.1007/s40121-024-01036-8. Erratum for: Infect Dis Ther. 2024 Oct;13(10):2105-2121. doi: 10.1007/s40121-024-01007-z. PMID: 39212853
DOI
10.1007/s40121-024-01007-z
ISSN
2193-8229
PubMed ID
39212853
COinS